FGL1 as a modulator of plasma D‐dimer levels: Exome‐wide marker analysis of plasma tPA, PAI‐1, and D‐dimer
Background Use of targeted exome‐arrays with common, rare variants and functionally enriched variation has led to discovery of new genes contributing to population variation in risk factors. Plasminogen activator‐inhibitor 1 (PAI‐1), tissue plasminogen activator (tPA), and the plasma product D‐dimer...
Gespeichert in:
Veröffentlicht in: | Journal of thrombosis and haemostasis 2021-08, Vol.19 (8), p.2019-2028 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Use of targeted exome‐arrays with common, rare variants and functionally enriched variation has led to discovery of new genes contributing to population variation in risk factors. Plasminogen activator‐inhibitor 1 (PAI‐1), tissue plasminogen activator (tPA), and the plasma product D‐dimer are important components of the fibrinolytic system. There have been few large‐scale genome‐wide or exome‐wide studies of PAI‐1, tPA, and D‐dimer.
Objectives
We sought to discover new genetic loci contributing to variation in these traits using an exome‐array approach.
Methods
Cohort‐level analyses and fixed effects meta‐analyses of PAI‐1 (n = 15 603), tPA (n = 6876,) and D‐dimer (n = 19 306) from 12 cohorts of European ancestry with diverse study design were conducted, including single‐variant analyses and gene‐based burden testing.
Results
Five variants located in NME7, FGL1, and the fibrinogen locus, all associated with D‐dimer levels, achieved genome‐wide significance (P |
---|---|
ISSN: | 1538-7933 1538-7836 1538-7836 |
DOI: | 10.1111/jth.15345 |